Advances in the treatment of endocrine disorders.
D000172:Acromegaly / Q000188:drug therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000307:Adrenal Gland Diseases / Q000188:drug therapy; D000310:Adrenal Gland Neoplasms / Q000628:therapy; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003480:Cushing Syndrome / Q000628:therapy; D004393:Dwarfism, Pituitary / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000188:drug therapy / Q000628:therapy*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy; D013006:Growth Hormone / Q000627:therapeutic use; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy; D007018:Hypopituitarism / Q000188:drug therapy; D007037:Hypothyroidism / Q000188:drug therapy; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy; D010900:Pituitary Diseases / Q000188:drug therapy; D011379:Prognosis; D013959:Thyroid Diseases / Q000188:drug therapy; D013963:Thyroid Hormones / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D013963:Thyroid Hormones; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone